As compared to post-menopausal patients, breast cancers arising in premenopausal patients seem to harbour more aggressive features, namely higher tumour stage and more frequent luminal B-like biology within the subgroup of hormone receptor-positive tumours [3]. Here, NR4A1 is linked to neoplasm.